This application is for a cooperative agreement to continue the Cancer Partnership as a triad with participation from Vanderbilt-lngram Cancer Center (VICC), Meharry Medical College (MMC) and Tennessee State University (TSU). Program administrators of the National Cancer Institute (NCI) of the National Institutes of Health (NIH) will be part of the Program Steering Committee for this Program and will be consulted and kept apprised of progress. As such. Dr. Nelson Aguila, Diversity Training Branch in the Center to Reduce Cancer Health Disparities at the NCI, has provided the requisite approval for the submission of this triad application. A copy of this approval letter is included in Section 14 "Letters of Support". The Partnership was developed in 1999 and continues with the goal of strengthening cancer research capabilities of MMC and TSU as well as providing exposure and resources for faculty at VICC focusing on cancer disparities research, mentoring junior faculty and training the next generation of minority students and postdoctoral fellows. The administrative leadership teams of the three institutions are jointly responsible for the overall management, coordination and support of the components in the Partnership. We have a longstanding and close working relationship with the administrative teams of our Partner organizations, resulting in numerous supportive interactions. The internal activities of the Partnership will be accomplished by the respective Administrative Cores in close collaboration with the Internal Advisory Committee and Program Steering Committees of the Partnership. Figure 1 represents the organizational structure of the parties involved in the Partnership. The figure also depicts direct lines of communication between the Administrative Cores based at the VICC, MMC and TSU and the other participating components.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-SRLB-Y)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Vanderbilt University Medical Center
United States
Zip Code
Brown, Shyretha; Whalen, Margaret (2015) Tributyltin alters secretion of interleukin 1 beta from human immune cells. J Appl Toxicol 35:895-908
Vaiopoulou, Anna; Gazouli, Maria; Papadopoulou, Aggeliki et al. (2015) Serum protein profiling of adults and children with Crohn disease. J Pediatr Gastroenterol Nutr 60:42-7
Cui, Yong; Deming-Halverson, Sandra L; Beeghly-Fadiel, Alicia et al. (2014) Interactions of hormone replacement therapy, body weight, and bilateral oophorectomy in breast cancer risk. Clin Cancer Res 20:1169-78
Hull, Pamela C; Williams, Elizabeth A; Khabele, Dineo et al. (2014) HPV vaccine use among African American girls: qualitative formative research using a participatory social marketing approach. Gynecol Oncol 132 Suppl 1:S13-20
Patel, Kushal; Kanu, Mohamed; Liu, Jianguo et al. (2014) Factors influencing breast cancer screening in low-income African Americans in Tennessee. J Community Health 39:943-50
Rekhadevi, P V; Diggs, D L; Huderson, A C et al. (2014) Metabolism of the environmental toxicant benzo(a)pyrene by subcellular fractions of human ovary. Hum Exp Toxicol 33:196-202
Xie, Yingqiu; Liu, Shenji; Lu, Wenfu et al. (2014) Slug regulates E-cadherin repression via p19Arf in prostate tumorigenesis. Mol Oncol 8:1355-64